[MET] MetLife Thesis 2026: Group Benefits Operational Excellence + New Frontier Plan Anchor ROE Recovery
MetLife FY2025 revenue ~$71B with adj. EPS ~$8.85 and ROE ~11% (recovering from FY2023 trough ~6%, targeting 13-15% by FY2027 per New Frontier 2024 strategic plan). Group Benefits segment ($25B revenue, 89% combined ratio improving from 93% FY2022) is strategically distinctive — largest US employer benefits insurer serving 41,000+ employers + 90M+ lives. RIS pension risk transfer franchise top-3 US. Asia operations ($10B Japan + Korea) provides revenue diversification. CEO Michel Khalaf since May 2019. Capital return ~$5-6B/yr (dividend $1.5B + buybacks $3-4B) supports ~8-10% combined yield. FY2026 thesis: Group Benefits margin expansion + RIS PRT growth + Asia stable + MIM modest scaling drive ROE toward 13-15% target by FY2027; key risks: mortality reserve charges continuing, Asia demographic/currency challenges, RIS PRT competitive intensity from Athene/F&G/Prudential.
Key Takeaways
MetLife Inc.'s fiscal year 2025 (calendar year ended December 31, 2025) demonstrated the operational durability of the global diversified life insurance + retirement + employer benefits franchise through navigation of the multi-year strategic transformation under the New Frontier 2024 strategic plan articulated by CEO Michel Khalaf: revenue of approximately $70-72B (+~3-5% YoY), net income of approximately $5-5.5B, and adjusted EPS of approximately $8.50-9.00 on approximately 700M diluted shares. The strategic identity that distinguishes MetLife from peer life insurance + retirement companies (Prudential Financial covered separately as the closest US peer combining life insurance + retirement + asset management, AIG covered separately, plus selected European life insurers including Allianz Life + Manulife + Aegon, plus Asian competitors including AIA Group + Asia-focused life insurers) is the integrated platform combining the dominant US Group Benefits franchise (the largest US employer-benefits insurance provider serving approximately 41,000+ employer customers + approximately 90M+ covered group benefit lives) with the diversified geographic platform spanning Asia (Japan + Korea + selected emerging Asia), Latin America, EMEA, plus the MetLife Investment Management (MIM) asset management subsidiary at approximately $610B AUM. The investment thesis for MetLife in FY2026 centers on three structural questions: (1) whether the New Frontier 2024 strategic plan progresses toward the targeted ROE recovery (the multi-year plan targeting approximately 13-15% ROE by FY2027 versus the FY2024 baseline of approximately 10-11%) supported by Group Benefits operational excellence + Retirement & Income Solutions pension risk transfer + selected emerging strategic initiatives; (2) whether the Asia operations (primarily Japan + Korea, contributing approximately 14% of revenue + meaningful net income contribution) sustain through demographic transition + selected currency volatility; and (3) whether the MetLife Investment Management franchise continues capturing institutional limited partner allocations supporting AUM compounding plus operational margin expansion.
MetLife Inc.'s contemporary corporate identity emerged from the 1868 founding of the Metropolitan Life Insurance Company in New York, evolving through over 150 years of life insurance operations into the diversified global insurance + retirement franchise it is today. The 2000 IPO transitioned MetLife from mutual ownership structure to publicly traded company. Strategic milestones include the 2010 acquisition of Alico (American Life Insurance Company) from AIG for approximately $16B (the transformative deal that doubled MetLife's international footprint plus added meaningful Japan + selected emerging Asia operations), the 2017 spinoff of Brighthouse Financial (the variable annuity-focused life insurance subsidiary that removed tail-risk variable annuity operations from MetLife's balance sheet), the 2018-2019 strategic refocus under CEO Steven Kandarian (CEO 2011-2019) emphasizing operational excellence + selected divestitures, plus the 2019-present strategic transformation under CEO Michel Khalaf emphasizing the New Frontier strategic plan. Michel Khalaf, who has led MetLife since May 2019 (succeeding Steven Kandarian), brings deep international insurance operational experience including leading MetLife's Latin America + EMEA operations plus selected operational roles. The strategic identity that distinguishes contemporary MetLife from peer life insurance companies is the deliberate concentration on Group Benefits (the largest US employer benefits franchise) combined with the multi-decade Asia operations + selected emerging strategic positioning that creates revenue + earnings diversification beyond US-specific dynamics.
Business Structure
MetLife reports through six primary operational segments aligned with end-market and geographic categories.
Group Benefits (~$25B revenue, ~36% of total): The largest segment by revenue plus the strategically distinctive franchise. Products: group life insurance, group dental insurance, group disability insurance, group accident & health, plus selected emerging employer-benefits products. MetLife is the largest US employer-benefits insurance provider serving approximately 41,000+ employer customers + approximately 90M+ covered lives across employer-sponsored insurance plans. Combined ratio approximately 89-92% (favorable underwriting profitability).
Retirement & Income Solutions (RIS) (~$15B revenue, ~21% of total): US retirement products including:
- Pension Risk Transfer (PRT, the largest revenue contributor — corporate pension plans transferring liabilities to MetLife in exchange for premium payment) — MetLife is consistently top-3 in US PRT market by transaction volume.
- Group Annuities + Institutional Products (selected institutional retirement products).
- Individual Annuities (smaller scale post-Brighthouse spinoff).
Asia (~$10B revenue, ~14% of total): Primarily Japan + Korea operations:
- Japan: MetLife Insurance K.K. (the second-largest foreign life insurer in Japan after Aflac, plus selected dynamics versus Prudential Financial Japan operations covered alongside in PRU thesis).
- Korea: MetLife Korea (selected scale operations).
- Other Asia: Selected smaller market operations.
Latin America (~$7B revenue, ~10% of total): Mexico + Chile + Argentina + selected emerging Latin America operations.
EMEA (~$3B revenue, ~4% of total): Selected European + Middle East + Africa operations.
MetLife Holdings (~$10B revenue, ~14% of total): The legacy US individual insurance + selected closed blocks managed in run-off plus selected retained operations.
Corporate / MetLife Investment Management (MIM): MIM operates as MetLife's asset management subsidiary with approximately $610B AUM at FY2025 — selected institutional asset management plus management of MetLife insurance investment portfolio.
Key Core Metrics Performance
Revenue, Net Income, and EPS Trajectory (FY2021–FY2025)
| Fiscal Year | Total Revenue | Net Income | Adj. EPS | ROE |
|---|---|---|---|---|
| FY2021 | ~$70B | ~$6.5B | ~$8.20 | ~13% |
| FY2022 | ~$70B | ~$3.5B | ~$7.05 | ~9% |
| FY2023 | ~$67B | ~$1.6B | ~$7.40 | ~6% |
| FY2024 | ~$71B | ~$4.7B | ~$8.10 | ~10% |
| FY2025 | ~$71B | ~$5.2B | ~$8.85 | ~11% |
The pattern of net income volatility through FY2022-FY2023 reflects multiple factors: insurance investment portfolio mark-to-market valuations during Fed rate hikes affecting reported earnings, selected mortality + reserve adjustments, plus selected operational charges. ROE compression to approximately 6-10% through FY2022-FY2024 versus the FY2021 baseline of approximately 13% reflects these challenges; the FY2025 recovery to approximately 11% indicates progressive normalization toward the New Frontier 2024 plan targeted ROE of 13-15%.
Group Benefits Performance
| Period | Group Benefits Revenue ($B) | Combined Ratio | Net Income Contribution |
|---|---|---|---|
| FY2022 | ~$22.5 | ~93% | ~$1.0B |
| FY2023 | ~$23.7 | ~92% | ~$1.2B |
| FY2024 | ~$24.5 | ~90% | ~$1.5B |
| FY2025 | ~$25.5 | ~89% | ~$1.7B |
Group Benefits combined ratio improving from approximately 93% in FY2022 to approximately 89% in FY2025 reflects favorable claims experience plus disciplined underwriting plus selected pricing actions. Group Benefits is the most strategically distinctive franchise within MetLife — large addressable market (approximately $200B+ US employer-benefits insurance market) with MetLife capturing meaningful share plus stable recurring revenue dynamics.
MetLife Investment Management AUM
| Period | MIM AUM ($B) | MIM Revenue Contribution |
|---|---|---|
| FY2022 | ~$575 | ~$1.5B |
| FY2023 | ~$590 | ~$1.6B |
| FY2024 | ~$600 | ~$1.7B |
| FY2025 | ~$610 | ~$1.8B |
MIM AUM has been relatively stable at approximately $575-610B reflecting both the management of MetLife's substantial insurance investment portfolio (approximately $400B+ insurance assets) plus selected institutional asset management mandates. MIM has not been emphasized as a major strategic growth platform versus peer integrated insurance + asset management platforms (Apollo Athene, KKR Global Atlantic, Prudential PGIM) — MetLife's strategic positioning emphasizes insurance operations rather than scaling asset management as a meaningful third-party institutional franchise.
Market Evaluation
MetLife trades at approximately 8-12x forward adjusted EPS — value-leaning life insurance multiples that reflect both the dividend yield (approximately 3-4%) plus the operational complexity that has constrained valuation expansion. The bull case is New Frontier 2024 plan delivery + Group Benefits continued growth + Asia stable contribution + capital return acceleration: if the multi-year strategic plan progresses toward the targeted 13-15% ROE by FY2027 supported by Group Benefits operational excellence + RIS pension risk transfer expansion + selected emerging strategic initiatives, if Asia operations continue stable contribution at approximately 14% of revenue, and if capital return continues at approximately $5-6B annual pace, adj. EPS could approach $10-11 by FY2027 with potential multiple expansion as ROE recovery materializes. The bear case is sustained operational pressure + Asia challenges + RIS pension risk transfer competitive intensity: if MetLife continues experiencing periodic mortality + reserve adjustments, if Asia operations face demographic + currency challenges, or if RIS pension risk transfer market becomes more competitive (multiple competitors including Athene Holding + Fidelity & Guaranty Life + Prudential Financial + selected smaller all competing for PRT mandates), EPS growth could remain in the high-single-digits with multiple compression.
The New Frontier 2024 Plan and Group Benefits Strategic Position
The strategic argument that defines MetLife's contemporary investment thesis combines two structural elements: the New Frontier 2024 strategic plan that articulates the multi-year operational excellence + capital allocation roadmap plus the Group Benefits franchise that represents MetLife's most strategically distinctive operational positioning.
The New Frontier 2024 strategic plan: announced FY2024 by CEO Michel Khalaf, the plan articulates the multi-year strategic priorities through FY2027 emphasizing Group Benefits operational excellence + selected RIS expansion + selected emerging strategic investments + capital allocation discipline. The plan targets ROE recovery from approximately 10-11% baseline toward 13-15% by FY2027 — a meaningful operational improvement that requires sustained execution across multiple operational fronts. The strategic execution involves: Group Benefits combined ratio continued improvement (the segment combined ratio has progressed from approximately 93% to 89% supporting elevated underwriting profitability), RIS pension risk transfer transaction execution (multi-year market opportunity as corporate pension plans continue transferring liabilities to insurance companies), MIM asset management selective expansion (modest growth versus peer integrated insurance + asset management platforms), plus selected operational efficiency improvements supporting expense ratio reduction.
The Group Benefits franchise: MetLife's Group Benefits operations represent the largest US employer-benefits insurance provider, serving approximately 41,000+ employer customers + approximately 90M+ covered lives across products including group life insurance, group dental insurance, group disability insurance, group accident & health insurance, plus selected emerging employer-benefits products. The strategic value: employer-benefits insurance has structural advantages versus consumer insurance — recurring annual policy renewals, corporate customer relationships that are stickier than individual consumer relationships, plus the cross-selling opportunity across multiple benefits product categories. The competitive dynamic: MetLife competes with Cigna (covered indirectly through employer benefits + selected), UnitedHealth Group (covered separately), Aetna (CVS Health subsidiary), plus selected regional competitors — MetLife maintains the largest scale Group Life + Group Disability share with selected emerging share gains in dental + selected emerging benefits products.
The capital return discipline: MetLife has maintained approximately $5-6B annual capital return through dividend distribution ($1.5B annually based on $2.20/share dividend + selected emerging adjustments) + share repurchases ($3-4B annually). The capital return scale is substantial relative to peer life insurance companies — approximately 8-10% combined dividend + buyback yield supports total shareholder return even during periods when EPS growth is constrained by operational issues. The dividend has grown approximately 4-5% annually supporting MetLife's continued dividend track record.
